arrow
O

Ozan S. Kumru

university of kansas
H指数:20
被引数:1,750

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Study on Formulating a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons Learned for Future Technology Transfer

非洲本地制造多剂量冷冻干燥麻疹-风疹(MR)疫苗候选制剂的案例研究:实验室规模结果及对未来技术转移的启示

2026-10-140
OA
Developability assessments with four mRNA-LNP vaccine formulations comparing mouse immunogenicity, structural attributes, and stability profiles

可开发性评估:比较四种mRNA-LNP疫苗制剂的小鼠免疫原性、结构属性和稳定性特征

2026-02-110
OAAI
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates (vol 14, 2149, 2023)

一种基于铁蛋白的新型冠状病毒肺炎纳米颗粒疫苗,可在非人类灵长类动物中引发稳健,持久,广谱的中和抗血清 (第14卷,2149,2023)

2023-10-051
OAAI
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

一种基于铁蛋白的新型冠状病毒肺炎纳米颗粒疫苗,可在非人灵长类动物中引发强大,持久,广谱的中和抗血清

2023-04-1743
OAAI
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I-Screening of Preservative Combinations
2023-02-017
OAAI
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real- time and Accelerated Stability Studies
2023-02-016
PRE
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development
2022-11-016
OAAI
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
2022-06-0616
OAAI
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques

HBsAg病毒样颗粒上显示的SARS-CoV-2受体结合域在猕猴中引起保护性免疫

2022-03-1822
OAAI
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
2021-09-0764
OAAI